Market



Pfizer profit beats estimates on higher demand for COVID products

  • Revenue from the antiviral pill, Paxlovid, exceeded market estimates by more than $1 billion
  • Its antiviral treatment Paxlovid, whose demand has surged in recent months, is expected to further bolster revenue
By Reuters ·